Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Liver Cirrhosis 1Glioma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Urination × 1 year × Clear all
NCT06575452 2025-12-03

EPIGLIO

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Not yet recruiting
228 enrolled
CNS

Glioma

NCT03958136 2025-08-17

EPICURE_SEIN

Institut Cancerologie de l'Ouest

Phase NA Active not recruiting
289 enrolled
Breast

Breast Neoplasms

NCT07119957 2025-08-13

ProspEXPO

University Hospital, Angers

Phase NA Not yet recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡